Quarterly report · Q2
8095.TEDINET S100OPJO
Period2021-12-01 → 2022-05-31
Filed2022-07-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥24.9bn | 2021-12-01 → 2022-05-31 | Cons. | Net sales |
| Revenue | ¥72.3bn | 2020-12-01 → 2021-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥36.2bn | 2020-12-01 → 2021-05-31 | Cons. | Net sales |
| Operating income | ¥720m | 2021-12-01 → 2022-05-31 | Cons. | Operating income |
| Operating income | ¥1.5bn | 2020-12-01 → 2021-05-31 | Cons. | Operating income |
| Ordinary income | ¥835m | 2021-12-01 → 2022-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.4bn | 2020-12-01 → 2021-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2020-12-01 → 2021-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥1.5bn | 2021-12-01 → 2022-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.6bn | 2020-12-01 → 2021-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥933m | 2021-12-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.7bn | 2020-12-01 → 2021-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥976m | 2020-12-01 → 2021-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥928m | 2021-12-01 → 2022-05-31 | Cons. | Profit loss |
| Net income | ¥976m | 2020-12-01 → 2021-05-31 | Cons. | Profit loss |
| Total assets | ¥63.9bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥63.6bn | at 2021-11-30 | Cons. | Assets |
| Total assets | ¥60.3bn | at 2021-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥36.0bn | at 2022-05-31 | Cons. | Liabilities |
| Total liabilities | ¥36.5bn | at 2021-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥27.8bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥27.0bn | at 2021-11-30 | Cons. | Net assets |
| Net assets / equity | ¥25.4bn | at 2021-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.4bn | at 2022-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.9bn | at 2021-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.3bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.8bn | at 2021-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.9bn | at 2021-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.4bn | at 2020-11-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.3bn | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.3bn | 2020-12-01 → 2021-11-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2020-12-01 → 2021-05-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥23m | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.4bn | 2020-12-01 → 2021-11-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.5bn | 2020-12-01 → 2021-05-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.9bn | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥6.4bn | 2020-12-01 → 2021-11-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥4.6bn | 2020-12-01 → 2021-05-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥23.33 | 2021-12-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.08 | 2022-03-01 → 2022-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.86 | 2020-12-01 → 2021-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.06 | 2020-12-01 → 2021-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.06 | 2021-03-01 → 2021-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥46.63 | 2020-12-01 → 2021-11-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.76 | 2020-12-01 → 2021-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 43.5% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2021-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.1% | at 2021-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 57
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-12-01 → 2022-05-31 | ¥807,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-12-01 → 2022-05-31 | ¥807,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-12-01 → 2022-05-31 | −¥19m |
| Reconciling Itemsreconciling | revenue | 2021-12-01 → 2022-05-31 | −¥740m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-12-01 → 2022-05-31 | −¥740m |
| Reconciling Itemsreconciling | segment profit | 2021-12-01 → 2022-05-31 | ¥17m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥7.9bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥7.5bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥348m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-05-31 | ¥474m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥7.3bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥7.2bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥105m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2021-12-01 → 2022-05-31 | −¥66m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥4.4bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥4.3bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥52m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-05-31 | −¥38m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥6.1bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥5.9bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥235m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | segment profit | 2021-12-01 → 2022-05-31 | ¥353m |
| —segment total | revenue | 2021-12-01 → 2022-05-31 | ¥25.7bn |
| —segment total | revenue external | 2021-12-01 → 2022-05-31 | ¥24.9bn |
| —segment total | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥740m |
| —segment total | segment profit | 2021-12-01 → 2022-05-31 | ¥722m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-12-01 → 2022-05-31 | ¥25.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-12-01 → 2022-05-31 | ¥24.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥740m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-12-01 → 2022-05-31 | ¥704m |
| Reconciling Itemsreconciling | revenue | 2020-12-01 → 2021-05-31 | −¥641m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-12-01 → 2021-05-31 | −¥641m |
| Reconciling Itemsreconciling | segment profit | 2020-12-01 → 2021-05-31 | −¥10m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue | 2020-12-01 → 2021-05-31 | ¥12.1bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue external | 2020-12-01 → 2021-05-31 | ¥11.6bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2020-12-01 → 2021-05-31 | ¥500m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | segment profit | 2020-12-01 → 2021-05-31 | ¥726m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2020-12-01 → 2021-05-31 | ¥14.0bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2020-12-01 → 2021-05-31 | ¥14.0bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2020-12-01 → 2021-05-31 | ¥4m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2020-12-01 → 2021-05-31 | −¥350m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue | 2020-12-01 → 2021-05-31 | ¥4.1bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2020-12-01 → 2021-05-31 | ¥4.1bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2020-12-01 → 2021-05-31 | ¥36m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2020-12-01 → 2021-05-31 | ¥206m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue | 2020-12-01 → 2021-05-31 | ¥6.6bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue external | 2020-12-01 → 2021-05-31 | ¥6.5bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue intersegment | 2020-12-01 → 2021-05-31 | ¥102m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | segment profit | 2020-12-01 → 2021-05-31 | ¥923m |
| —segment total | revenue | 2020-12-01 → 2021-05-31 | ¥36.9bn |
| —segment total | revenue external | 2020-12-01 → 2021-05-31 | ¥36.2bn |
| —segment total | revenue intersegment | 2020-12-01 → 2021-05-31 | ¥641m |
| —segment total | segment profit | 2020-12-01 → 2021-05-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-12-01 → 2021-05-31 | ¥36.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-12-01 → 2021-05-31 | ¥36.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-12-01 → 2021-05-31 | ¥641m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-12-01 → 2021-05-31 | ¥1.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 638
| Item | Context | Value | Unit |
|---|---|---|---|
| Share of other comprehensive income of associates accounted for using equity method oci | Prior1YTDDuration | 211000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | CurrentYTDDuration | 112000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 23786000 | JPY |
| Other comprehensive income | CurrentYTDDuration | -7185000 | JPY |
| Comprehensive income | Prior1YTDDuration | 999603000 | JPY |
| Comprehensive income | CurrentYTDDuration | 920799000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 999603000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 925784000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | － | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | -4984000 | JPY |
| Income before income taxes | Prior1YTDDuration | 1552207000 | JPY |
| Income before income taxes | CurrentYTDDuration | 1463916000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 836066000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 1038167000 | JPY |
| Share based compensation expenses ope cf | Prior1YTDDuration | 23998000 | JPY |
| Share based compensation expenses ope cf | CurrentYTDDuration | 24447000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | -3587000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | -1046000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | -93631000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | 150338000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YTDDuration | 1747000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYTDDuration | -8199000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -26892000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -28667000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 28098000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 26931000 | JPY |
| Foreign exchange losses gains ope cf | Prior1YTDDuration | -29163000 | JPY |
| Foreign exchange losses gains ope cf | CurrentYTDDuration | -50693000 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YTDDuration | 5406000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYTDDuration | 7415000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | Prior1YTDDuration | -157000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | CurrentYTDDuration | -663894000 | JPY |
| Loss on retirement of noncurrent assets ope cf | Prior1YTDDuration | 21919000 | JPY |
| Loss on retirement of noncurrent assets ope cf | CurrentYTDDuration | 5435000 | JPY |
| Subsidy income ope cf | Prior1YTDDuration | － | JPY |
| Subsidy income ope cf | CurrentYTDDuration | -24900000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YTDDuration | -11000 | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYTDDuration | － | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | 379626000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | － | JPY |
| Decrease increase in trade receivables and contract assets ope cf | Prior1YTDDuration | － | JPY |
| Decrease increase in trade receivables and contract assets ope cf | CurrentYTDDuration | 1103647000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | 102195000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -800689000 | JPY |
| Decrease increase in returned assets ope cf | Prior1YTDDuration | － | JPY |
| Decrease increase in returned assets ope cf | CurrentYTDDuration | -40633000 | JPY |
| Decrease increase in accounts receivable other ope cf | Prior1YTDDuration | -29946000 | JPY |
| Decrease increase in accounts receivable other ope cf | CurrentYTDDuration | 49881000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | -750547000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -52026000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |